Chromocell Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $933 | $0 |
Gross Profit | -194 | 466 | -414 | |
EBITDA | -3,230 | -1,833 | -2,217 | -1,655 |
EBIT | -3,667 | -1,057 | -2,048 | |
Net Income | -3,448 | -1,967 | -1,926 | -1,694 |
Net Change In Cash | 0 | 0 | 933 | 0 |
Free Cash Flow | -447 | -632 | -670 | -177 |
Cash | 59 | 131 | 513 | 1,254 |
Basic Shares | 640 | 6,127 | 5,683 | 5,792 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,579 | -391 | ||
EBITDA | -7,571 | -6,862 | -1,627 | |
EBIT | -8,741 | -13,724 | -2,318 | |
Net Income | -7,955 | -7,380 | -7,380 | -2,458 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,792 | -981 | -981 | -1,567 |
Cash | 513 | 96 | 96 | 55 |
Basic Shares | 5,574 | 5,767 | 5,767 | 5,767 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.90 |
2024-06-30 | -$3.10 |
2024-03-31 | -$0.44 |
